Cure Alzheimer’s Fund is deeply concerned about several provisions of the President's proposed budget, specifically, the approximately 18% cut to the National Institutes of Health in general; and the approximately 18% cut to the National Institute on Aging.
The release Thursday, March 16, of the President’s Fiscal Year 2018 Budget Blueprint is the first step in a long process. There will be many opportunities for Cure Alzheimer’s Fund to offer its expertise to the Trump Administration and Congress about the need for continued and increased funding of Alzheimer’s disease research and the value of public-private partnerships in defeating this disease.
In the world of medicine, collaboration is key. Individuals can learn from each other, share their progress and inspire new approaches to developing cures. That’s the philosophy of FasterCures, Michael Milken’s organization that sponsors Partnering for Cures, an annual conference that brings together hundreds of leaders from around the world to accelerate getting new therapies into the hands of patients.
Cure Alzheimer's Fund is excited to share that the 21st Century Cures Act was today signed into law by President Obama. The legislation will substantially increase federal funding for medical research, and aims to improve and accelerate the approval process for new drug treatments.
The bill passed with overwhelming bipartisan support, showing widespread awareness of the need for more research funding and speedier drug development. Outside of government, the legislation was also championed by the drug industry, patient advocates, and academic institutions.
On December 5, 2016, we visited the National Institutes of Health for a conversation with Dr. Richard Hodes, director of the National Institute on Aging (NIA), about public and private efforts being made to advance Alzheimer's research.
Cure Alzheimer’s Fund is thankful to the Senate Appropriations Subcommittee for their support of increasing vital funding for Alzheimer’s disease research with the NIH. With a $400 million increase, the proposed budget for Alzheimer’s research at the NIH will reach close to $1.4 billion, nearly triple what it was three years ago, demonstrating the understanding in Congress of the need to continue to fund research to address the disease.
Cure Alzheimer's Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer's.